Bio Essence Corporation
BIOE
$0.19
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 206.72% | 2,154.50% | 902.37% | 1.56% | 521.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 206.72% | 2,154.50% | 902.37% | 1.56% | 521.34% |
| Cost of Revenue | 258.56% | 11,225.00% | 725.55% | -23.65% | 624.00% |
| Gross Profit | 178.94% | 1,450.49% | 969.60% | 18.27% | 477.40% |
| SG&A Expenses | 77.84% | -54.10% | 10.49% | -64.16% | -44.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 160.43% | 25.25% | 213.01% | -56.42% | -4.26% |
| Operating Income | 356.37% | 205.22% | 26,300.00% | 109.77% | 137.09% |
| Income Before Tax | 362.11% | 204.57% | 3,828.62% | 101.08% | 128.25% |
| Income Tax Expenses | 1,200.00% | -- | -- | -- | 0.00% |
| Earnings from Continuing Operations | 350.92% | 199.81% | 3,828.62% | 101.08% | 127.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 350.92% | 199.81% | 3,828.62% | 101.08% | 127.77% |
| EBIT | 356.37% | 205.22% | 26,300.00% | 109.77% | 137.09% |
| EBITDA | 524.63% | 205.32% | 25,014.63% | 109.77% | 137.22% |
| EPS Basic | 250.00% | 185.19% | 3,971.43% | 100.95% | 128.07% |
| Normalized Basic EPS | 270.00% | 188.24% | 3,480.00% | 101.02% | 128.57% |
| EPS Diluted | 250.00% | 185.19% | 7,328.57% | 100.95% | 128.07% |
| Normalized Diluted EPS | 270.00% | 188.24% | 3,480.00% | 101.02% | 128.57% |
| Average Basic Shares Outstanding | 26.11% | 18.26% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 26.11% | 18.26% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |